3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelomonocytic, Acute
4
Leukemia, Myeloid, Acute
4
Leukemia, Monocytic, Acute
4
Leukemia, Megakaryoblastic, Acute
4
Leukemia, Erythroblastic, Acute
4
Lymphoma, Non-Hodgkin
3
Wilms Tumor
2
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Melanoma
2
Medulloblastoma
2
Leukemia, Myelomonocytic, Chronic
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Ependymoma
2
Congenital Abnormalities
2
Breast Neoplasms
2
Brain Neoplasms
2
Anemia, Refractory, with Excess of Blasts
2
Xanthogranuloma, Juvenile
1
Interventions
Temozolomide
4
Capecitabine
4
Bevacizumab
3
Leucovorin
2
Fluorouracil
2
Everolimus
2
temsirolimus
1
sapanisertib
1
regorafenib
1
pentetreotide
1
pazopanib
1
motesanib diphosphate
1
irinotecan sucrosofate
1
gallium Ga 68 dotatate
1
dehydroftorafur
1
batifiban
1
aflibercept
1
Sunitinib
1
Sorafenib
1
Sirolimus
1
Panobinostat
1
Oxaliplatin
1
Octreotide
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Fentanyl
1
Etoposide
1
Doxorubicin
1
Disulfides
1
Cytidine Triphosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Somatostatinoma
×
tipifarnib
×
Clear all
No trials found.